Literature DB >> 22643488

TennCare disenrollment and avoidable hospital visits in Davidson County, Tennessee.

Janice S Emerson1, Pamela C Hull, Van A Cain, Meggan Novotny, Rodney E Stanley, Robert S Levine.   

Abstract

The objective of this study was to determine if an association existed between the mid-2005 TennCare (Medicaid) disenrollment and increases in uninsured ambulatory care sensitive condition (ACSC) non-admitted ER visits and inpatient hospitalizations in Davidson County, Tennessee (= the city of Nashville). Logistic regression modeling, using an interactive term for insurance category x year, indicated that the effect of no insurance on ACSC ER visits increased by 18% from 2003 to 2007 (p<.001), but no significant effect was found for uninsured ACSC inpatient hospitalizations. These greater odds of ACSC ER visits among uninsured patients were associated with a 60% increase in hospitals' bad debt write offs during this same time period. Therefore, the TennCare disenrollment was associated with increased likelihood of uninsured ACSC non-admitted ER visits and greater financial losses for Davidson County hospitals during this time period.

Entities:  

Mesh:

Year:  2012        PMID: 22643488     DOI: 10.1353/hpu.2012.0002

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN: 1049-2089


  3 in total

1.  Medicaid Disenrollment and Disparities in Access to Care: Evidence from Tennessee.

Authors:  Wafa W Tarazi; Tiffany L Green; Lindsay M Sabik
Journal:  Health Serv Res       Date:  2016-06-03       Impact factor: 3.402

2.  Purged from the Rolls: A Study of Medicaid Disenrollment in Iowa.

Authors:  Natoshia M Askelson; Patrick Brady; Brad Wright; Suzanne Bentler; Elizabeth T Momany; Peter Damiano
Journal:  Health Equity       Date:  2019-12-16

3.  Disparity in breast cancer mortality by age and geography in 10 racially diverse US cities.

Authors:  Dominique Sighoko; Bijou R Hunt; Bethliz Irizarry; Karriem Watson; David Ansell; Anne Marie Murphy
Journal:  Cancer Epidemiol       Date:  2018-02-22       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.